The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
95491902 9549190 2 F 20120304 20160706 20130924 20160711 EXP CA-MERCK-1309CAN010406 MERCK 62.00 YR F Y 46.00000 KG 20160711 OT CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
95491902 9549190 1 PS SAPHRIS ASENAPINE MALEATE 1 Sublingual 5 MG, BID Y 22117 5 MG SUBLINGUAL TABLET BID
95491902 9549190 2 SS DIVALPROEX SODIUM. DIVALPROEX SODIUM 1 Oral 250 MG, QAM U 0 250 MG QD
95491902 9549190 3 SS DIVALPROEX SODIUM. DIVALPROEX SODIUM 1 Oral 250 MG, HS U 0 250 MG QD
95491902 9549190 4 I LAMOTRIGINE. LAMOTRIGINE 1 Oral 200.0 MG, HS Y 0 200 MG TABLET QD
95491902 9549190 5 SS PRISTIQ EXTENDED-RELEASE DESVENLAFAXINE SUCCINATE 1 Oral 150 MG, QAM (STRENGHT 50 MG, 100 MG) Y 0 150 MG PROLONGED-RELEASE TABLET QD
95491902 9549190 6 SS PRISTIQ EXTENDED-RELEASE DESVENLAFAXINE SUCCINATE 1 Oral 150 MG, QAM, (STRENGHT 50 MG, 100 MG) Y 0 150 MG QD
95491902 9549190 7 C TRAZODONE HYDROCHLORIDE. TRAZODONE HYDROCHLORIDE 1 Oral 50 MG, HS U 0 50 MG CREAM QD
95491902 9549190 8 C CETIRIZINE HYDROCHLORIDE. CETIRIZINE HYDROCHLORIDE 1 Oral 5 MG, DAILY U 0 5 MG TABLET QD
95491902 9549190 9 C CLONAZEPAM. CLONAZEPAM 1 Oral 1 MG, HS U 0 1 MG TABLET QD
95491902 9549190 10 C HYDROCORTISONE ACETATE. HYDROCORTISONE ACETATE 1 Topical UNK, BID U 0 CREAM BID
95491902 9549190 11 C LAMOTRIGINE. LAMOTRIGINE 1 Unknown U 0 TABLET
95491902 9549190 12 C LORAZEPAM. LORAZEPAM 1 Unknown U 0
95491902 9549190 13 C OLANZAPINE. OLANZAPINE 1 Topical AS DIRECTED U 0 CREAM
95491902 9549190 14 C PREMARIN ESTROGENS, CONJUGATED 1 Unknown U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
95491902 9549190 1 Bipolar disorder
95491902 9549190 2 Bipolar disorder
95491902 9549190 4 Bipolar disorder
95491902 9549190 5 Bipolar disorder
95491902 9549190 6 Bipolar disorder
95491902 9549190 7 Product used for unknown indication
95491902 9549190 8 Product used for unknown indication
95491902 9549190 9 Product used for unknown indication
95491902 9549190 10 Product used for unknown indication
95491902 9549190 11 Product used for unknown indication
95491902 9549190 12 Product used for unknown indication
95491902 9549190 13 Product used for unknown indication
95491902 9549190 14 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
95491902 9549190 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
95491902 9549190 Contusion
95491902 9549190 Glossodynia
95491902 9549190 Oropharyngeal pain
95491902 9549190 Pruritus
95491902 9549190 Rash
95491902 9549190 Swelling

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
95491902 9549190 1 20120304 20120324 0
95491902 9549190 2 2010 0
95491902 9549190 3 2010 0
95491902 9549190 4 2010 20120328 0
95491902 9549190 5 20120328 0
95491902 9549190 6 20120328 0